RISANKIZUMAB for Maternal exposure timing unspecified: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where RISANKIZUMAB was used for Maternal exposure timing unspecified.
Most Reported Side Effects for RISANKIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product storage error | 396 | 15.0% | 0 | 3 |
| Drug ineffective | 206 | 7.8% | 2 | 40 |
| Psoriasis | 138 | 5.2% | 2 | 25 |
| Crohn's disease | 103 | 3.9% | 1 | 23 |
| Arthralgia | 100 | 3.8% | 2 | 13 |
| Off label use | 100 | 3.8% | 1 | 9 |
| Product temperature excursion issue | 88 | 3.3% | 0 | 1 |
| Diarrhoea | 72 | 2.7% | 1 | 7 |
| Fatigue | 70 | 2.7% | 0 | 4 |
| Rash | 64 | 2.4% | 1 | 10 |
| Pruritus | 61 | 2.3% | 0 | 12 |
| Headache | 58 | 2.2% | 2 | 13 |
| Therapeutic product effect decreased | 56 | 2.1% | 0 | 11 |
| Abdominal pain | 50 | 1.9% | 0 | 28 |
| Urticaria | 49 | 1.9% | 0 | 1 |
Other Indications for RISANKIZUMAB
Psoriasis (1,051)
Crohn's disease (863)
Product used for unknown indication (340)
Colitis ulcerative (162)
Psoriatic arthropathy (161)
Generalised pustular psoriasis (18)
Inflammatory bowel disease (14)
Pustular psoriasis (14)
Rheumatoid arthritis (7)
Skin disorder (7)
Other Drugs Used for Maternal exposure timing unspecified
VALPROATE (1,477)
ADALIMUMAB (1,280)
NATALIZUMAB (492)
RITONAVIR (486)
EMTRICITABINE\TENOFOVIR DISOPROXIL (333)
LOPINAVIR\RITONAVIR (278)
DIVALPROEX (254)
INTERFERON BETA-1A (245)
DIMETHYL (212)
ATAZANAVIR (169)